Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Prednisone; Procarbazine; Vinblastine; Vincristine
- Indications Hodgkin's disease
- Focus Therapeutic Use
Most Recent Events
- 05 Oct 2020 Biomarkers information updated
- 07 Oct 2013 Planned end date changed from 1 Jun 2017 to 1 Jul 2017 as reported by ClinicalTrials.gov.
- 06 Sep 2012 Planned end date changed from 1 May 2015 to 1 Jun 2017 as reported by ClinicalTrials.gov.